Advertisement

Topics

Imaging Agent Can Change Plans for Recurrent Prostate Cancer

04:45 EST 13 Feb 2018 | Medscape

Clinicians viewing scans using the imaging agent 18F-fluciclovine changed their management plans in 61% of cases of biochemical recurrence of prostate cancer.
Medscape Medical News

Original Article: Imaging Agent Can Change Plans for Recurrent Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Imaging Agent Can Change Plans for Recurrent Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement